Stockhub

Cardax, Inc.: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

29 August 2022

  • curprev 11:2911:29, 29 August 2022 >Nick 822 bytes +822 Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == Cardax, Inc., a biopharmaceutical company, develops and commercializes dietary supplements for inflammatory health and pharmaceuticals for chronic diseases driven by inflammation and oxidative stress. It offers ZanthoSyn, an inflammatory supplement for health and longevity that provides astaxanthin with enhanced absorption and purity. The company sells ZanthoSyn primarily through e-commerce and wholesale channels. It is als..."
Retrieved from "https://stockhub.co/research/Cardax,_Inc."